Pacira Biosciences

Youtube Subscribe

Open: 37.84 Close: 37.57 Change: -0.27

Try an AI to get informed about investing in Pacira Biosciences Stock.

How much time have you spent trying to decide whether investing in Pacira Biosciences? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pacira Biosciences are: …

Concept Map

Semantic Network

Stock Summary

Pacira BioSciences reports mixed Q2 earnings; updates FY23 outlook. Q2 Non-GAAP EPS of $0.78 beats by $0.02. Pacira Biosciences has an average price target.

Today's Summary

Pacira BioSciences Inc. is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. Q2 sales came in at $170 million and earnings were up 30%. Pacira Biosciences, Inc. hiring senior facilities mechanic - night shift in San Diego, CA.

Today's News

Pacira BioSciences Inc. is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. Q2 sales came in at $170 million and earnings were up 30%. Pacira Biosciences, Inc. hiring senior facilities mechanic - night shift in San Diego, CA.

Stock Profile

" Pacira BioSciences reports mixed Q2 earnings; updates FY23 outlook. Q2 Non-GAAP EPS of $0.78 beats by $0.02. Seeking Alpha Join the Summer Sale! Home Analysis News Market Data Investing Groups. Pacira Biosciences Inc reported earnings per share of $0.96 for the current quarter and recorded sales of $182.3 million. Pacira BioSciences has an average price target of $58.25 with a high of $68.00 and a low of $50.00. Analysts expect Pacira Biosciences Inc. share price to average $61.78 over the next year. TD Cowen raised Pacira BioSciences from a “market perform” rating to an “outperform’s’ price target on Thursday."

Keywords

The game is changing. There is a new strategy to evaluate Pacira Biosciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pacira Biosciences are: Pacira, Inc, BioSciences, provider, nonopioid, pain, management, and the most common words in the summary are: therapeutic, pharmaceutical, bioscience, pharma, biotech, technology, biotechnology, . One of the sentences in the summary was: Pacira BioSciences Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #pharmaceutical #bioscience #pharma #biotech #technology #biotechnology.

Read more →

Youtube Subscribe

---